Zynerba Pharmaceuticals Announces Oral Presentation

Zynerba Pharmaceuticals

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the acceptance of an oral presentation at The Society for the Study of Behavioural Phenotypes (SSBP) 24th International Research Symposium, which will be held in Oslo, Norway, September 8-10, 2022.

Oral Presentation Details

Title: An Open-Label, Tolerability and Efficacy Study of ZYN002 (Cannabidiol) Administered as a Transdermal Gel to Children and Adolescents with 22q11.2 Deletion Syndrome (INSPIRE)
Date: September 8, 2022
Time: 3:30 p.m. CEST (9:30 a.m. EDT)

The Company states that a copy of the presentation slides will be made available on the Zynerba corporate website following the presentation at http://zynerba.com/publications/. Additional meeting information can be found on the SSBP website at https://ssbp.org.uk/.

More For You

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.